Cara Therapeutics | CARA - Capital De Empréstimo





Capital De Empréstimo Alterar Data
Acadia Pharmaceuticals USD 0 0 2025-03
Alterity Therapeutics Limited AUD 43.68K 59.53K 2025-12
Cara Therapeutics USD 0 0 2025-03
Cassava Sciences USD 0 0 2024-12
Chugai Pharma JPY 4.53B 1.95B 2024-12
Cipla INR 3.82B 840.2M 2026-03
Clal Biotechnology ILS 25.96M 18.48M 2023-12
Compugen USD 0 0 2024-12
CSL USD 10.42B 273M 2025-12
Grifols EUR 9.95B 722.93M 2025-12
Halozyme Therapeutics USD 1.94B 1.79M 2026-06
J&J USD 37.34B 183M 2026-06
Neurocrine Biosciences USD 169.5M 500K 2023-03
Pacira USD 363.12M 4.53M 2026-06
Pfizer USD 60.5B 70M 2026-06
RedHill Biopharma USD 900K 710K 2025-12
Supernus Pharmaceuticals USD 400.38M 21.13M 2022-03
Vanda Pharmaceuticals USD 3.15M 3.15M 2024-12